• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Mogroside IIIe

Mogroside IIIe

Product ID M568266
Cas No. 88901-37-5
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $180.30 In stock
5 mg $510.80 In stock
10 mg $871.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Mogroside IIIe is a minor sweet element of the traditional Chinese medicinal herb Siraitia grosvenori (Luohanguo).

Product Info

Cas No.

88901-37-5

Purity

≥98%

Formula

C48H82O19

Formula Wt.

963.15

IUPAC Name

(2R,3R,4S,5S,6R)-2-[[(3S,8S,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Synonym

Mogroside III-E; Mogroside IIIe; Mogroside e; HY-N6928

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

M568266 MSDS PDF

Info Sheet

M568266 Info Sheet PDF

References

Bhusari S, Rodriguez C, Tarka S, et al. Comparative in vitro metabolism of purified mogrosides derived from monk fruit extracts. Regul Toxicol Pharmacol. 2021 Mar;120:104856. PMID: 33387567.

Xue W, Mao J, Chen Q, et al. Mogroside IIIe alleviates high glucose-induced inflammation, oxidative stress and apoptosis of podocytes by the activation of AMPK/SIRT1 signaling pathway. Diabetes Metab Syndr Obes. 2020 Oct 20;13:3821-3830. PMID: 33116729.

Zou C, Zhang Q, Zhang S. Mogroside IIIe attenuates gestational diabetes mellitus through activating of AMPK signaling pathway in mice. J Pharmacol Sci. 2018 Nov;138(3):161-166. PMID: 30316692.

Tao L, Cao F, Xu G, et al. Mogroside IIIe attenuates LPS-induced acute lung injury in mice partly through regulation of the TLR4/MAPK/NP-kB axis via AMPK activation. Phytother Res. 2017 Jul;31(7):1097-1106. PMID: 28512854.

Tao L, Yang J, Cao F, et al. Mogroside IIIe, a novel anti-fibrotic compound, reduces pulmonary fibrosis throguh toll-like receptor 4 pathways. J Pharmacol Exp Ther. 2017 May;361(2):268-279. PMID: 28280123.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • H1695

    S-Hexylglutathione

    Glutathione-S-transferase inhibitor.

    ≥98%
  • T1979

    Tetrahydrocoptisine

    Alkaloid compound originally found in Corydalis...

    ≥98%
  • M174446

    Meleagrin

    FabI inhibitor

    ≥99%
  • G7342

    GSK-2126458

    p110α PI3K and mTOR inhibitor.

    ≥99%
  • P1869

    Perindopril Erbumine

    ACE inhibitor.

    ≥95%
  • H1794

    Hexamethonium Bromide Hydrate

    Non-depolarizing NMJ blocker; nAChR antagonist....

    ≥98%
  • R0248

    Ramatroban

    CRTH2 inhibitor, TxA2 antagonist.

    ≥98%
  • C6935

    Crizotinib

    ALK, ROS1, c-MET inhibitor.  
    ≥98%
  • S0225

    SAG Dihydrochloride

    Smoothened agonist.

    ≥98%
  • G4481

    Glucagon-like Peptide I Amide (7-36), human

    Endogenous peptide hormone, GLP-1 fragment, inv...

    ≥95%
  • T3203

    Tianeptine Sodium Hydrate

    μOR and δOR agonist, D2/D3 DA potentiator.

    ≥98%
  • S5869

    Sorafenib Tosylate

    c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...

    ≥99%
  • V014451

    Valiltramiprosate

    beta-Amyloid anti-oligomer and aggregation inhi...

    ≥99%
  • O9334

    Oxibendazole

    Benzimidazole; microtubule polymerization inhib...

    ≥98%
  • P3210

    Picoplatin

    Pt-based DNA cross-linker.

    ≥98%
  • M5746

    Molsidomine

    NO donor; annexin A2 inhibitor.

    ≥98%
  • P2012

    PF-04217903

    Triazolopyrazine; c-MET inhibitor.

    ≥98%
  • N8460

    NVP-BHG712

    EphB4 inhibitor.

    ≥98%
  • T1674

    Terbutaline Sulfate

    β2-adrenergic agonist, potential ENaC activator. ...
    ≥98%
  • A5234

    Amisulpride

    5-HT7 and D2/3 antagonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only